UK health officials confirmed on Saturday that there were seven deaths due to clots among people who received the AstraZeneca vaccine against covid-19.
Among the 30 cases reported up to March 24, unfortunately, there are the deaths of seven people “, the UK drug regulator told the news agency France-Press (AFP)
The UK drug regulator (MHRA) had announced on Friday that so far they had been 30 cases of blood clots reported in people inoculated with the Anglo-Swedish vaccine, produced in partnership with the University of Oxford.
Of the 30 cases reported until March 24, 22 were cerebral venous thrombosis and 8 were less severe thrombosis, associated with low platelets. And the people in question received only the first dose of the vaccine.
In all, 18 million doses of the AstraZeneca vaccine have been administered so far: 15.8 million for the first dose and 2.2 million for the second.
MHRA also considered, on Friday, that “the risk of having this specific type of blood clot is very small” and that the number and nature of these adverse reactions “are not uncommon compared to other types of vaccines used regularly”, advising the British not to back down on this vaccine.
However, so far, these cases have not been reported among people who have received the Pfizer vaccine, the second vaccine that is being widely distributed in the UK, the regulator confirmed.
The AstraZeneca vaccine, which changed its name to Vaxzevria in the European Union, it has been under fire after several cases of clots have been reported.
But until then there were no known problems in the United Kingdom, one of the biggest recipients of this vaccine.
Germany recently announced that it would restrict vaccination with AstraZeneca to those over 60 years of age.
The Netherlands was the last country to determine suspension AstraZeneca vaccine in children under 60 years of age.
Decisions taken at a time when the European Medicines Agency and the World Health Organization continue to defend vaccination with this vaccine.
Currently, four vaccines are approved in the EU: Pfizer / BioNTech, Moderna, Vaxzevria and Janssen (Johnson & Johnson group).
Get the latest news delivered to your inbox
Follow us on social media networks